Cancer Research Cell Death Mechanisms and Cancer Therapy  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 1235-1238, March 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, G. M.
Right arrow Articles by McMillan, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, G. M.
Right arrow Articles by McMillan, T. J.

DNA Strand Break Rejoining Defect in xrs-6 Is Complemented by Transfection with the Human Ku80 Gene1

Gillian M. Ross2, John J. Eady, Natasha P. Mithal, Cyd Bush, G. Gordon Steel, Penny A. Jeggo and Trevor J. McMillan

Radiotherapy Research Unit, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG [G. M. R., J. J. E., N. P. M., C. B., G. G. J., T. J. M.], and MRC Cell Mutation Unit, University of Sussex, Falmer, Brighton, Sussex, [P. A. J.], United Kingdom

The radiosensitive mutant xrs-6, derived from Chinese hamster ovary cell line CHO-K1, has been demonstrated to be defective in DNA double-strand break repair and also in its proficiency to undergo V(D)J recombination. Recent work has provided both genetic and biochemical evidence that the Mr 80,000 subunit of the Ku protein is able to complement the radiosensitivity and the V(D)J recombination defect in the xrs-6 mutant. We demonstrate here that complementation of the radiosensitive phenotype in xrs-6 cells by the introduction of Ku80 cDNA is accompanied by the concomitant restoration of DNA double-strand break rejoining proficiency to almost that of the parental CHO-K1 cells, as measured both by neutral single-cell microgel electrophoresis (Comet) technique and by pulsed-field gel electrophoresis. These results provide further biochemical evidence for the involvement of the Ku protein in the repair of DNA double-strand breaks.

1 This work was supported by a Medical Research Council Clinical Science Fellowship (to G. M. R.) and the Cancer Research Campaign.

2 To whom requests for reprints should be addressed.

Received 12/27/94. Accepted 2/ 2/95.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Guirouilh-Barbat, E. Rass, I. Plo, P. Bertrand, and B. S. Lopez
Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends
PNAS, December 26, 2007; 104(52): 20902 - 20907.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Wang, W. Wu, W. Wu, B. Rosidi, L. Zhang, H. Wang, and G. Iliakis
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways
Nucleic Acids Res., December 4, 2006; 34(21): 6170 - 6182.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. Noel, C. Godon, M. Fernet, N. Giocanti, F. Megnin-Chanet, and V. Favaudon
Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis.
Mol. Cancer Ther., March 1, 2006; 5(3): 564 - 574.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Reis, N. Giocanti, C. Hennequin, F. Megnin-Chanet, M. Fernet, R. Filomenko, A. Bettaieb, E. Solary, and V. Favaudon
A role for PKC{zeta} in potentiation of the topoisomerase II activity and etoposide cytotoxicity by wortmannin
Mol. Cancer Ther., October 1, 2005; 4(10): 1457 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I.-Y. Chang, C.-K. Youn, H.-B. Kim, M.-H. Kim, H.-J. Cho, Y. Yoon, Y.-S. Lee, M.-H. Chung, and H. J. You
Oncogenic H-Ras Up-regulates Expression of Ku80 to Protect Cells from {gamma}-Ray Irradiation in NIH3T3 Cells
Cancer Res., August 1, 2005; 65(15): 6811 - 6819.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Jensen and P. M. Glazer
Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions
PNAS, April 20, 2004; 101(16): 6134 - 6139.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. W. G. van Putten, H. J. M. Groen, K. Smid, G. J. Peters, and H. H. Kampinga
End-joining Deficiency and Radiosensitization Induced by Gemcitabine
Cancer Res., February 1, 2001; 61(4): 1585 - 1591.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
E. Marangoni, N. Foray, M. O'Driscoll, S. Douc-Rasy, J. Bernier, J. Bourhis, and P. Jeggo
A Ku80 fragment with dominant negative activity imparts a radiosensitive phenotype to CHO-K1 cells
Nucleic Acids Res., December 1, 2000; 28(23): 4778 - 4782.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. K. Bishop, U. Ear, A. Bhattacharyya, C. Calderone, M. Beckett, R. R. Weichselbaum, and A. Shinohara
Xrcc3 Is Required for Assembly of Rad51 Complexes in Vivo
J. Biol. Chem., August 21, 1998; 273(34): 21482 - 21488.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.